Navigation Links
Top OTC Brand deploys Semantelli AETracker to monitor Adverse Events in Facebook
Date:11/27/2012

BRIDGEWATER, N.J., Nov. 27, 2012 /PRNewswire-iReach/ -- Semantelli Corporation announced today that a $400 million OTC brand has deployed Semantelli's AETracker® to detect and manage adverse events, drug overdose and product complaints reported by consumers in brand sponsored Facebook pages, enabling it to continue its marketing plan with confidence in remaining compliant in its dialogue with customers.

(Photo: http://photos.prnewswire.com/prnh/20121127/CG19358)

AETracker™ is the healthcare industry's only software solution that detects and manages Adverse Events in company sponsored social media and mobile applications 24/7.

"This particular OTC brand's decision to monitor patient safety 24/7 in their Facebook pages demonstrates employing a social media strategy is possible within the healthcare segment while assuring compliance. The brand has had tremendous sales success on Facebook. Ensuring compliance in these medium is another step in the right direction, and shows the brand's responsibility towards safety", said Siva Nadarajah, CEO of Semantelli Corp.

According to Consumer Healthcare Products Association (CHPA), 240 million people in the U.S. currently use OTC medicines. The availability of OTC medicines provides $102 billion in value to the U.S. healthcare system annually. A Semantelli study found that Facebook has become the primary customer relations hub for many of the OTC brands and some brand Facebook pages generate close to 40,000 interactions a week.

In August of 2011, Semantelli launched AETracker to help healthcare companies monitor and manage adverse events reported on company owned Facebook pages. Semantelli later released a version of AETracker to monitor mobile apps and other sponsored social outlets. Currently AETracker has been deployed by some of the top 10 pharma, OTC and other healthcare companies.

About AETracker™
Powered by patent pending technology and 24x7 pharmacovigilance support, AETracker helps pharmaceutical companies monitor and respond to potential adverse events, product complaints, misinformation and off-label comments on company sponsored social media and mobile applications.

About Semantelli
Semantelli is the leader in social listening solutions for the global life sciences industry. Companies use Semantelli's compliance sensitive solutions to monitor social media and other digital assets to find previously unknown early warnings, threats, and opportunities. Semantelli customers have found immediate ROI, ranging from spotting early compliance warnings, new trends, micro-targeted promotions to engaging customers who have shown signs of switching to competitor brands.

Semantelli is a privately-held company headquartered in Bridgewater, NJ.

For more information go to: http://www.semantelli.com/pharma/aetracker

Contacts:
Semantelli Corporation
991, US Hwy 22, Suite 200
Bridgewater, NJ  08807
1-866-277-9057
John.jason@semantelli.com

Media Contact: John Jason Semantelli Corp., 1-866-277-9057, john.jason@semantelli.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Semantelli Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
2. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
3. Sarnova Launches Curaplex Private Label Brand
4. Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand
5. Health-Conscious Women are Sixty Percent More Likely to Prefer Popular Brand-Name Drugs, Even if They Cost More
6. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
7. Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales
8. Market and Product Forecasts: Top 20 Oncology Therapy Brands 2011-21 - Avastin fails to top any individual market in 2011
9. Positioning Strategies Effectively Minimize Cannibalization of a Legacy Brand When Expanding a Product Portfolio
10. Branded Generics in South East Asia: Current and Future Opportunities
11. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):